—Is it asthma? Is it chronic obstructive pulmonary disease? In a genome-wide association study, researchers in the U.K. have determined signals that are associated with both diseases. Here are the ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

—According to findings of a large study of patient care in England and Wales, hospitalized patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma have different ...

Background: Asthma and COPD can significantly affect patients and pose a substantial economic burden for both patients and managed-care plans. This study compares utilization outcomes in patients with ...

CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of individuals with respiratory symptoms, 21% had undiagnosed COPD or asthma. Researchers found ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. COPD exacerbations went down by 51% in patients with ...

A diagnostic algorithm was evaluated for its ability to gauge the presence of asthma or chronic obstructive pulmonary disease (COPD), in a new analysis. An asthma/chronic obstructive pulmonary disease ...

Individuals frequently seek medical care from clinics for issues related to asthma; the predominant symptoms for these patients will be cough, difficulty with breathing, and wheeze. One of the ...

Add Yahoo as a preferred source to see more of our stories on Google. Lead author Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital in Ottawa, Ontario, Canada, described ...

Asthma and chronic obstructive pulmonary disease patients will receive better care closer to home under a landmark £10million partnership Care for ...

CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing ...